Chang-Fang Chiu

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study

Chiun Hsu, Hsiao‐Hui Tsou, Shyh-Jer Lin et al. · Hepatology · 2013 · 275 citations · Full text

Medicine, Hematology, Oncology +10

Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis

Ying‐Chun Shen, Chee‐Jen Chang, Chiun Hsu et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 147 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients

Chang-Fang Chiu, Ming-Hsui Tsai, Hsien-Chang Tseng et al. · Oral Oncology · 2008 · 125 citations

Life Sciences, Genetics, Molecular Genetics +13

Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy

Chia-Hsien Wu, Li-Yuan Bai, Ming-Hsui Tsai et al. · Scientific Reports · 2016 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17